The Hematology/Oncology Fellowship Program is a three-year program with training in both clinical and translational research. The clinical training qualifies fellows for board certification in both hematology and oncology. The first year for most fellows consists of clinical rotations, including dedicated outpatient rotations, inpatient hematology and oncology consultations, inpatient leukemia/lymphoma service, bone marrow transplantation, and electives. The second and third years are more flexible and are tailored to the specific interests of the individual fellows, involving approximately three months of patient-directed training each year with the remainder of the time devoted to academic research.
All first year fellows attend two clinics per week. One clinic is devoted to patients with benign or malignant hematological disorders. The other clinic is a "continuity experience" for patients with a variety of solid tumors. Second and third year fellows have one or two clinics depending on their career goals. Second and third year fellows spend most of their time on clinical or translational research under the guidance of faculty mentors.
This program provides preparation for dual certification in hematology and oncology. At the end of training, graduates will be well qualified to pursue academic careers and independent biomedical research.
Application for the program should be made in the second year of the applicant’s house staff training. Applications should be submitted before the end of December, to ERAS (Electronic Residency Application Service) one and a half to 2 years before matriculation is desired. We participate in the Medical Specialty Matching Program (MSMP).
The patient is the center of our universe, and we emphasize strong clinical skills, attention to detail, and the development of outstanding communication skills and professionalism as we care for people with blood disorders and cancer. Patient care spans the spectrum of prevention, diagnosis, treatment, follow-up, and effective palliative care and end-of-life care. We strongly support clinical trials as the best option for quality care of patients with cancer and hematologic disorders. The clinical experience will include general inpatient and outpatient consultations on oncologic and hematologic problems, and specialized experience in the management of intensively treated, critically ill cancer patients on inpatient oncology and hematology units.
The first year of fellowship consists of clinical rotations. All the clinical rotations described below are one month in length and may be done once or twice.
Inpatient Medical Oncology - This is a month long rotation of the medical oncology service with a second or third year resident. The team consists of residents, medical students, and pharmacists. The fellow on the service helps direct the oncology care, sees the consults related to patients with cancer or suspected cancers, and is responsible for teaching attending rounds once a week to resident and students. At the end of this rotation it is expected that the fellow will have a better appreciation of inpatient oncology, hospice and palliative care, and further enhance their skills as a teachers.
Inpatient Malignant Hematology Service - The fellow on this service develops expertise in handling patients with malignant hematological disorders, such as acute leukemias, and lymphomas. The fellow develops procedural skills that are needed such as review and interpretation of blood smears and bone marrow biopsies, and intrathecal chemotherapy. At the end of the rotation is expected that the fellow will have a better appreciation for malignant hematology, particularly leukemia and lymphoma, and will also have enhanced teaching skills.
Bone Marrow Transplantation Service - The bone marrow transplant (BMT) service at the Audie L Murphy V A Hospital is primarily an inpatient rotation with the attending on the bone marrow transplant service. The fellow is responsible for the day to day management of the patients on the bone marrow inpatient service in partnership with the BMT team. At the end of the rotation it is expected that the fellow will have a better appreciation of indications for bone marrow transplantation, acute and chronic toxicities, and pre and post transplant follow-up of patients. An elective rotation is also offered at the Adult Blood and Marrow Stem Cell Transplant Program at the Methodist Hospital and Texas Transplant Institute.
Hematology Consult Service - The Hematology consult service covers hematology consults throughout the hospitals. There are regular rounds, and exceptional conferences with faculty and colleagues in hemato-pathology. At the end of the rotation it is expected that the fellow will be proficient in the clinical management of complex benign and malignant hematological disorders.
Outpatient Months - The outpatient rotation varies in length. The fellow rotates through a variety of clinics that deal with hematologic and malignant diseases. Our clinics include benign and malignant hematology, thoracic oncology, breast oncology, neuro oncology, melanoma, gastrointestinal oncology, genitourinary oncology, geriatric oncology, head and neck oncology, and experimental therapeutics and clinical trials evaluation and follow-up clinic. At the end of the outpatient rotations the fellow will have a much better understanding of the variety of outpatient benign and malignant diseases.
Continuity Clinics - The first year fellow has two continuity clinics, one of the clinics in the first year is hematology, and the other clinic consists of a variety of solid tumors. In the second and third years, fellows have continuity clinics but the number of clinics depends on their career goals and research focus.
Elective Rotations - Elective rotations include geriatric oncology, experimental therapeutics, gynecologic oncology, radiation oncology, palliative care, transfusion medicine, hemostasis and thrombosis, and hematopathology, genetics, and others.
Conferences & Curriculum
Fellows participate in weekly hematology, and medical oncology lecture series, journal clubs, translational and basic-science seminars, and special series of small-group discussions that encompass topics dealing with communication skills, performance and quality improvement, professionalism, cancer-care, and humanistic qualities important for a career in hematology/oncology. Multidisciplinary tumor boards cover all aspects of malignant hematology and subspecialty medical oncology care.
Active-learning seminars cover basic science topics related to hematology-oncology, and clinical trials methodology and trial-design.
The hematology and medical oncology fellowship curriculum incorporates the curricula recommended by the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO). It is revised frequently to reflect the rapid advances in our fields, to keep pace with the changes to graduate medical education standards, and most importantly to offer innovative approaches to learn hematology and medical oncology. The fellowship program effectively partners with ASH and ASCO in promoting education and research opportunities for fellows.
Research and Scholarly Activity
Fellows work with mentors to develop ideal portfolios of research and scholarly activities. Clinical Investigator Track: Fellows work with mentors on clinical trial design and develop skills in all aspects of clinical protocol development and the care of the patient on clinical trials. Fellows are mentored to apply for ASCO/AACR and ASH Workshops in clinical and translational research. Extensive experience in Phase-I trials, biomarkers, and translational research is offered. Active participation in NCI Cooperative Group Clinical Trials (SWOG) is strongly encouraged. Translational Research & Basic Science Track: Fellows are paired with mentors in laboratory based research with funding from training grants and fellows are expected to develop research and manuscript/grant-writing skills. In addition to these tracks, fellows may choose to work on healthcare disparities research, prevention research, and other programs of the CTRC, an NCI-designated cancer center.
Application for the program should be made in the second year of the applicant’s house staff training. Applications should be submitted before the end of December, one and a half to two years before matriculation is desired. We participate in the Medical Specialty Matching Program (MSMP). Occasionally, unexpected openings sometimes occur after match so that qualified applicants interested in our program should contact the department even past appropriate deadlines. The Division of Hematology/Oncology accepts applications on the Electronic Residency Application Service (ERAS) Fellowship Application website. The following documents should be submitted to the ERAS electronic document office:
- Personal statement describing your long term career goals and plans for research
- 3 letters of recommendation. 1 letter must be provided by your Department of Medicine Chair or Residency Program Director.
- Medical Student Performance Evaluation (MSPE)/Dean's Letter
- Medical School Transcript
- USMLE scores
- Wallet-sized color photo
*The University of Texas Health Science Center at San Antonio only accepts J-1 visas and permanent residents.*
2015 Interview Season
ERAS opens to applicants: July 15, 2014
Programs begin to download applicant information: July 30, 2014
All information must be submitted: : September 15, 2014
Interviews: August 2014 – October 2014
Match Results: December 3, 2014
Fellowship Training Begins: July 1, 2015
If you have questions regarding the program or its application process please contact our Fellowship Program Coordinator, Maria Miller at firstname.lastname@example.org or (210) 450-1667.